MGEE vs REGN · P/E 25, $3.28B cap vs P/E 14, rev $14.34B
MGE Energy Inc (MGEE) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
MGE Energy Inc (MGEE) is a utilities - regulated electric company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
MGEE does not have a complete income-statement cache yet.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MGEE currently screens at market cap $3.28B and trailing P/E 25.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MGEE and REGN stock pages for the full models.
Not investment advice.